Brown Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-7,492
| Closed | -$668K | – | 1178 |
|
|
2017
Q4 | $668K | Sell |
7,492
-143
| -2% | -$12.8K | ﹤0.01% | 792 |
|
|
2017
Q3 | $711K | Sell |
7,635
-194
| -2% | -$18.1K | ﹤0.01% | 746 |
|
|
2017
Q2 | $711K | Hold |
7,829
| – | – | ﹤0.01% | 759 |
|
|
2017
Q1 | $687K | Hold |
7,829
| – | – | ﹤0.01% | 723 |
|
|
2016
Q4 | $648K | Buy |
7,829
+1,329
| +20% | +$110K | ﹤0.01% | 728 |
|
|
2016
Q3 | $601K | Sell |
6,500
-7,087
| -52% | -$655K | ﹤0.01% | 718 |
|
|
2016
Q2 | $1.06M | Buy |
13,587
+8,196
| +152% | +$638K | ﹤0.01% | 591 |
|
|
2016
Q1 | $445K | Buy |
5,391
+940
| +21% | +$77.6K | ﹤0.01% | 744 |
|
|
2015
Q4 | $466K | Sell |
4,451
-74
| -2% | -$7.75K | ﹤0.01% | 706 |
|
|
2015
Q3 | $477K | Buy |
4,525
+2,060
| +84% | +$217K | ﹤0.01% | 700 |
|
|
2015
Q2 | $337K | Sell |
2,465
-3,483
| -59% | -$476K | ﹤0.01% | 714 |
|
|
2015
Q1 | $741K | Sell |
5,948
-815
| -12% | -$102K | ﹤0.01% | 609 |
|
|
2014
Q4 | $611K | Sell |
6,763
-386
| -5% | -$34.9K | ﹤0.01% | 649 |
|
|
2014
Q3 | $516K | Buy |
7,149
+335
| +5% | +$24.2K | ﹤0.01% | 661 |
|
|
2014
Q2 | $424K | Buy |
6,814
+1,759
| +35% | +$109K | ﹤0.01% | 713 |
|
|
2014
Q1 | $345K | Buy |
+5,055
| New | +$345K | ﹤0.01% | 754 |
|